The 2025 ELAVAY Advocacy Intelligence Benchmark Report analyzes how 70+ pharma, biotech, and med device companies are transforming patient engagement into strategic business impact.
A system to track, benchmark, and evolve Advocacy as a core function of commercial success.
It’s the most comprehensive analysis of how Advocacy teams shape market readiness, access, and trust — from preclinical to post-launch.
Already in Use by Leading Advocacy & Engagement Teams
Advocacy leaders across oncology, rare disease, immunology, and neuroscience are using the ELAVAY Benchmark Report to:
Trusted by patient advocacy teams at…
To ensure alignment and context, access to the report is available through a 1:1 strategy briefing with the ELAVAY team.